Renaissance Technologies
APGN

Renaissance Technologies’s Apexigen, Inc. Common Stock APGN Stock Holding History

Renaissance Technologies’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-44,150
Closed -$19K – 4285
2023
Q2 		$19K Buy
44,150
+29,338
+198% +$13.9K ﹤0.01% 3782
2023
Q1 		$7K Buy
+14,812
New +$17.8K ﹤0.01% 3906

Renaissance Technologies's APGN Position: Q3 2023 in Review

Renaissance Technologies sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 44,150 shares — an estimated $19K sold.

Renaissance Technologies first reported a position in APGN in Q1 2023 and held it in 2 quarters. The position peaked at $19K in Q2 2023. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Renaissance Technologies reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 44,150 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $19K.
  • Renaissance Technologies first reported a position in Apexigen, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Renaissance Technologies's Apexigen, Inc. Common Stock position peaked at $19K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.